158 related articles for article (PubMed ID: 21901364)
1. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4.
Chen S; Liu AR; An FM; Yao WB; Gao XD
Age (Dordr); 2012 Oct; 34(5):1211-24. PubMed ID: 21901364
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease.
Zago AM; Carvalho FB; Rahmeier FL; Santin M; Guimarães GR; Gutierres JM; da C Fernandes M
Mol Neurobiol; 2024 May; 61(5):2631-2652. PubMed ID: 37919602
[TBL] [Abstract][Full Text] [Related]
3. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of glucagon-like peptide-1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus.
Wang D; Jiang L; Feng B; He N; Zhang Y; Ye H
J Diabetes Investig; 2020 Jan; 11(1):39-51. PubMed ID: 31199578
[TBL] [Abstract][Full Text] [Related]
5. The effect of intra-nasal co-treatment with insulin and growth factor-rich serum on behavioral defects, hippocampal oxidative-nitrosative stress, and histological changes induced by icv-STZ in a rat model.
Ghaffari MK; Rafati A; Karbalaei N; Haghani M; Nemati M; Sefati N; Namavar MR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4833-4849. PubMed ID: 38157024
[TBL] [Abstract][Full Text] [Related]
6. Failure of the Brain Glucagon-Like Peptide-1-Mediated Control of Intestinal Redox Homeostasis in a Rat Model of Sporadic Alzheimer's Disease.
Homolak J; Babic Perhoc A; Knezovic A; Osmanovic Barilar J; Salkovic-Petrisic M
Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356351
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.
Grieb P
Mol Neurobiol; 2016 Apr; 53(3):1741-1752. PubMed ID: 25744568
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer's Disease Model in Mice.
El Sayed NS; Kandil EA; Ghoneum MH
Front Pharmacol; 2021; 12():666502. PubMed ID: 34366841
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the chemical constituents and anti-Alzheimer's disease effects of Uncaria rhynchophylla and Uncaria tomentosa.
Xu QQ; Shaw PC; Hu Z; Yang W; Ip SP; Xian YF; Lin ZX
Chin Med; 2021 Oct; 16(1):110. PubMed ID: 34706756
[TBL] [Abstract][Full Text] [Related]
10. Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
McNeilly AD; Gallagher JR; Evans ML; de Galan BE; Pedersen-Bjergaard U; Thorens B; Dinkova-Kostova AT; Huang JT; Ashford MLJ; McCrimmon RJ;
Diabetologia; 2023 Jul; 66(7):1340-1352. PubMed ID: 37015997
[TBL] [Abstract][Full Text] [Related]
11. The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.
Talbot K; Wang HY
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S12-25. PubMed ID: 24529520
[TBL] [Abstract][Full Text] [Related]
12. Ellagic Acid Reverses Alterations in the Expression of AMPA Receptor and Its Scaffolding Proteins in the Cerebral Cortex and Memory Decline in STZ-sporadic Alzheimer' s Disease Mouse Model.
Singh NAK; Prasad S
Psychopharmacology (Berl); 2024 Jun; ():. PubMed ID: 38842699
[TBL] [Abstract][Full Text] [Related]
13. Diet-induced diabetes is associated with lower hippocampal glycogen and reduced glycogenolysis following local exogenous insulin.
McNay EC
J Neurochem; 2024 May; 168(5):760-764. PubMed ID: 37885343
[TBL] [Abstract][Full Text] [Related]
14. CSF amino acid profiles in ICV-streptozotocin-induced sporadic Alzheimer's disease in male Wistar rat: a metabolomics and systems biology perspective.
Barzegar Behrooz A; Latifi-Navid H; Lotfi J; Khodagholi F; Shojaei S; Ghavami S; Fahanik Babaei J
FEBS Open Bio; 2024 May; ():. PubMed ID: 38769074
[TBL] [Abstract][Full Text] [Related]
15. Insights into Gastrointestinal Redox Dysregulation in a Rat Model of Alzheimer's Disease and the Assessment of the Protective Potential of D-Galactose.
Homolak J; Varvaras K; Sciacca V; Babic Perhoc A; Virag D; Knezovic A; Osmanovic Barilar J; Salkovic-Petrisic M
ACS Omega; 2024 Mar; 9(10):11288-11304. PubMed ID: 38496956
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.
Tweedie D; Rachmany L; Rubovitch V; Lehrmann E; Zhang Y; Becker KG; Perez E; Miller J; Hoffer BJ; Greig NH; Pick CG
Exp Neurol; 2013 Jan; 239():170-82. PubMed ID: 23059457
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.
Duarte AI; Candeias E; Correia SC; Santos RX; Carvalho C; Cardoso S; Plácido A; Santos MS; Oliveira CR; Moreira PI
Biochim Biophys Acta; 2013 Apr; 1832(4):527-41. PubMed ID: 23314196
[TBL] [Abstract][Full Text] [Related]
20. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).
Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
